A Case for Diagnosis: Pemphigus Vulgaris? Pemphigus Erythematosus? Presented by Dr. A. Benson Cannon.†
I. Z., a man aged 61, of Russian-Jewish descent, was previously presented before this section in March, 1949. In July of that year aureomycin therapy was begun, in a dosage of 2 gm. daily. Within two weeks there was an almost complete remission. In September aureomycin therapy was discontinued for four days and the patient manifested bullae on his neck. It was discontinued for four weeks in January, 1950, and he had a recurrence of lesions on the face and neck. Since Feb. 1, 1950, he has been on a maintenance dose of 250 mg. after meals and 500 mg. at bedtime. No new bullae have appeared, and the patient feels that the use of aureomycin has been the most effective treatment he has ever had. Pruritus returns whenever he fails to take the drug.
Costello MJ, Sachs W. NEW YORK ACADEMY OF MEDICINE, SECTION OF DERMATOLOGY AND SYPHILOLOGY. AMA Arch Derm Syphilol. 1951;64(2):218–224. doi:10.1001/archderm.1951.01570080102026
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: